Press "Enter" to skip to content

Biogen scraps development of therapy for rare brain disease

Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain disease after the treatment failed a mid-stage trial, the latest setback in attempts to develop a therapy for the disorder.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/TwrIOczTL40/biogen-scraps-development-of-therapy-for-rare-brain-disease-idINKBN1YH1I6

Also Read:   Cannabis abstinence tied to memory improvement in adolescents, young adults